Chronic Kidney Disease Requiring HemodialysisPeer supportNCT07125976
The Effect of Peer Support on Disease Adaptation and Self-Care Ability in Individuals Diagnosed With Chronic Kidney Failure
A study testing peer support in people with Chronic Kidney Disease Requiring Hemodialysis, run by pınar dogan at 1 site in Turkey (Türkiye).
Trial summary
This study was designed as an interventional, pretest-posttest controlled trial to examine the effects of peer interaction on disease adaptation and self-care ability in patients newly diagnosed with chronic kidney failure and starting dialysis. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Chronic Kidney Disease Requiring Hemodialysis
- What is being tested?
- peer support
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 64 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Sep 2024to 30 Apr 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Those receiving hemodialysis treatment for at most 6 months
- Not having mental illness according to DSM
- Without multiple chronic diseases
- Who agreed to participate in the study
Who cannot join
- Hospital stay longer or shorter than 1 week
- Treatment complications developed
Trial locations and contacts
1 site in 1 country.
About this study
This study was designed as an interventional, pretest-posttest controlled trial to examine the effects of peer interaction on disease adaptation and self-care ability in patients newly diagnosed with chronic kidney failure and starting dialysis. The main hypothesis:
H1: Structured peer support provided to patients receiving hemodialysis treatment has a positive effect on their level of adaptation to the disease.
Read more
H2: Structured peer support provided to patients receiving hemodialysis treatment has a positive effect on their self-care power.
Researchers will compare control group to see if adaptation to the dieases and self-care power.
Patients in the intervention group received peer support during their hospital stay, while those in the control group followed the routine clinical process.
Read the detailed description
This study was conducted with 64 patients in the nephrology clinic of a Training and Research Hospital in Istanbul. Data were collected using the Personal Information Form, the Chronic Illness Adaptation Scale, and the Self-Management of Chronic Illness Scale. Patients in the intervention group received peer support during their hospital stay, while those in the control group followed the routine clinical process. Participants in the intervention group took part in a structured peer support program, with pre-test data collected through the Self-Care Management Scale in Chronic Illness and the Chronic Illness Adaptation Scale. The program consisted of 4-6 sessions over one week, each lasting 30-45 minutes, focusing on disease information, self-care behaviors, psychosocial coping, and motivation, delivered by trained peers of similar age and gender. Post-test data were collected after the program to assess changes and analyze the effect of structured peer support.
- Being tested
- peer support
- Keywords
- Chronic Kidney Disease, Disease Adaptation, Self-care Ability, Peer Interaction
- Medical subject headings
- Renal Insufficiency, Chronic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
peer supportBehavioural
This intervention is a one-week, structured peer support program for patients in the first six months of hemodialysis treatment.
| Study group | Role | What they receive |
|---|---|---|
| Peer Support group | Experimental | In this group, structured peer support was provided for 1 week in addition to routine care practices applied in the clinic. Receives: Behavioral: peer support |
| Control group | No intervention | group monitored with routine clinical care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Chronic disease adaptation scale
It was used to determine the level of adaptation of hemodialysis patients to the disease. The minimum possible score on the scale is 25, and the maximum is 125. Higher scores on the scale indicate an increased level of adaptation to the illness.
Measured: Day 1, upon hospital admission) and at discharge (average of 7 days after admission.
Self-care management scale
It was used to measure patients' ability to manage their self-care. The possible score on the scale ranges from 35 to 175, and higher scores indicate better self-care management.
Measured: Day 1, upon hospital admission) and at discharge (average of 7 days after admission.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Aug 2025
- Study start1 Sep 2024
- Primary completion30 Oct 2024
- Study completion30 Apr 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Chronic Kidney Disease Requiring HemodialysisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Experimental study with pre-post test control group
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 64 participants (actual)
Sponsor and investigators
- Lead sponsor
- pınar dogan
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, pınar dogan, Istanbul Medipol University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07125976
- Sponsor's protocol ID
- 29384756
- Acronym
- Peer support
- Status last verified
- Aug 2025
- First submitted
- 5 Jul 2025
- Last updated
- 20 Aug 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Study protokol may be share for 1 year
Study at a glance
From the registry record, last updated by the sponsor on 20 Aug 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Peer Support on Disease Adaptation and Self-Care Ability in Individuals Diagnosed With Chronic Kidney Failure
- ClinicalTrials.gov ID
- NCT07125976
- Acronym / sponsor ID
- Peer support / 29384756
- Keywords
- Chronic Kidney Disease, Disease Adaptation, Self-care Ability, Peer Interaction
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 64 participants (actual)
- Lead sponsor
- pınar doganUniversity, hospital or other
- Study start
- 1 Sep 2024 (actual)
- Primary completion
- 30 Oct 2024 (actual)
- Study completion
- 30 Apr 2025 (actual)
- First posted
- 15 Aug 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study was designed as an interventional, pretest-posttest controlled trial to examine the effects of peer interaction on disease adaptation and self-care ability in patients newly diagnosed with chronic kidney failure and starting dialysis. The main hypothesis:
H1: Structured peer support provided to patients receiving hemodialysis treatment has a positive effect on their level of adaptation to the disease.
H2: Structured peer support provided to patients receiving hemodialysis treatment has a positive effect on their self-care power.
Researchers will compare control group to see if adaptation to the dieases and self-care power.
Patients in the intervention group received peer support during their hospital stay, while those in the control group followed the routine clinical process.
Detailed description
This study was conducted with 64 patients in the nephrology clinic of a Training and Research Hospital in Istanbul. Data were collected using the Personal Information Form, the Chronic Illness Adaptation Scale, and the Self-Management of Chronic Illness Scale. Patients in the intervention group received peer support during their hospital stay, while those in the control group followed the routine clinical process. Participants in the intervention group took part in a structured peer support program, with pre-test data collected through the Self-Care Management Scale in Chronic Illness and the Chronic Illness Adaptation Scale. The program consisted of 4-6 sessions over one week, each lasting 30-45 minutes, focusing on disease information, self-care behaviors, psychosocial coping, and motivation, delivered by trained peers of similar age and gender. Post-test data were collected after the program to assess changes and analyze the effect of structured peer support.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
- Model description
- Experimental study with pre-post test control group
| Arm | Type | Receives |
|---|---|---|
| Peer Support group | Experimental | Behavioral: peer supportIn this group, structured peer support was provided for 1 week in addition to routine care practices applied in the clinic. |
| Control group | No intervention | –group monitored with routine clinical care |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (4 listed)
- Those receiving hemodialysis treatment for at most 6 months
- Not having mental illness according to DSM
- Without multiple chronic diseases
- Who agreed to participate in the study
Key exclusion criteria (2 listed)
- Hospital stay longer or shorter than 1 week
- Treatment complications developed
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| peer supportThis intervention is a one-week, structured peer support program for patients in the first six months of hemodialysis treatment. | Behavioural | Peer Support group |
Primary outcome
Chronic disease adaptation scale
Time frame: Day 1, upon hospital admission) and at discharge (average of 7 days after admission.
It was used to determine the level of adaptation of hemodialysis patients to the disease. The minimum possible score on the scale is 25, and the maximum is 125. Higher scores on the scale indicate an increased level of adaptation to the illness.
Self-care management scale
Time frame: Day 1, upon hospital admission) and at discharge (average of 7 days after admission.
It was used to measure patients' ability to manage their self-care. The possible score on the scale ranges from 35 to 175, and higher scores indicate better self-care management.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Aug 2025.
- Individual participant dataSharing planned: Yes. Study protokol may be share for 1 year
Related trials for Chronic Kidney Disease Requiring Hemodialysis
Recruiting
DIALysis With EXpanded Solute Removal
Chronic Kidney Disease Requiring Hemodialysis, End-Stage Kidney Disease (ESKD)
RecruitingPhase 2
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Recruiting
Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients
Chronic Kidney Disease Requiring Hemodialysis
Recruiting
Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
Chronic Kidney Disease (CKD) Stage 5, Kidney Dysfunction Requiring Dialysis (KDRD)
Recruiting
Pumpkin Seed Oil as a Nutraceutical for Hemodialysis Patients
End Stage Renal Disease, Chronic Kidney Disease Requiring Chronic Dialysis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing peer support in people with Chronic Kidney Disease Requiring Hemodialysis, run by pınar dogan at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Chronic disease adaptation scale (time frame: Day 1, upon hospital admission) and at discharge (average of 7 days after admission.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2025.